- AuthorisedTherapeutic exploratory (Phase II)
A Phase 2, Randomized, Masked, Placebo-Controlled Study of Subcutaneously Administered ADX-038 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
This study is looking at a new treatment called ADX-038 for a serious eye condition called geographic atrophy (GA), which is a late form of age-related macular degeneration (AMD). Researchers want to see if this treatment can slow down the growth of GA.
For: Geographic atrophy secondary to age-related macular degenerationGermany · Portugal · Italy - RecruitingPHASE1, PHASE2
Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
This study is testing a new medicine called ADX-038 for a rare blood condition called PNH. It's looking at how safe it is, what effects it has on the body, and how the body handles it, first in healthy people and then in PNH patients.
For: Paroxysmal Nocturnal Hemoglobinuria (PNH)Australia · United Kingdom